Trial Profile
Clinical Trials Insight: 700043742
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2009
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary) ; Antihyperglycaemics; Insulin; Metformin; Pioglitazone; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Apr 2009 New trial record.
- 01 Apr 2009 Results have been published in Endocrine Practice.